Flow Cytometry in Oncology and Immunology Market Set for Growth Amid Increasing Global Cancer Prevalence

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry in Oncology and Immunology Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

As per the latest market research report, the global flow cytometry in oncology and immunology market is poised for significant growth. With a jump from $1.70 billion in 2022 to a projected $1.89 billion in 2023, at a robust CAGR of 11.03%, the industry looks set to embrace an upward trajectory. Despite facing headwinds from geopolitical tensions and supply chain disruptions, the sector remains on course to achieve an estimated $2.79 billion by 2027, with a steady CAGR of 10.2%.

The increasing burden of cancer worldwide is a primary driver fueling the market's expansion. The application of flow cytometry in clinical settings and research is becoming increasingly crucial to understanding and combating both cancer and immunological disorders. With cancer cases projected to rise to unprecedented levels in the coming decades, the need for advanced flow cytometry solutions is more critical than ever.

Leading the charge in innovation, key industry players are integrating state-of-the-art technologies to elevate research outcomes in both oncology and immunology. Recent launches such as cutting-edge cloud-based software systems are streamlining the flow cytometry process for researchers, providing higher-quality studies with faster insights.

North America stands at the forefront of the market, accounting for the largest share in this domain. The comprehensive report covers an extensive geographical spectrum that includes Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Highlights of the report include:

  • Detailed segmentation of the market into categories such as immunology and oncology.
  • In-depth analysis of technologies employed within flow cytometry, including cell-based and bead-based classification.
  • Exploration of market applications in translational research, clinical research, and other end-user scenarios.
  • Evaluation of the flow cytometry service industry, detailing various services provided by key market participants.

A selection of companies mentioned in this report includes

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Becton Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Agilent Technologies Inc.
  • Sartorius AG
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Sysmex Partec GmbH
  • OPKO Health Inc.
  • Miltenyi Biotec
  • NeoGenomics Laboratories Inc.
  • Luminex Corporation
  • Q2 Solutions LLC
  • Enzi Biochem Inc.
  • DiaSorin S.p.A;BioLegend Inc.
  • Cytek Biosciences Inc.
  • Cell Signaling Technology Inc.
  • Standard BioTools Inc.
  • Sony Biotechnology Inc.
  • NanoCellect Biomedical Inc.
  • Nexcelom Bioscience LLC
  • CytoReason.

For more information about this report visit https://www.researchandmarkets.com/r/cazh60

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Flow Cytometry in Oncology and Immunology Market